TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34710538

Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) at 2 mA for 20 minutes
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 35
Study: 32266494

Group type: EXPERIMENTAL
Intervention: Endurance training (EN, n=10)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Concurrent training (CON, n=13)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (C, n=12)
Number of subjects: 35
Study: 33611623

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study: 32236370

Group type: EXPERIMENTAL
Intervention: Team-based learning
Number of subjects: 25

Group type: COMPARATOR
Intervention: Lecture classes
Number of subjects: 25
Study: 34319948

Group type: EXPERIMENTAL
Intervention: Video tool for informed consent
Number of subjects: 91

Group type: COMPARATOR
Intervention: Traditional consent
Number of subjects: 91
Study: 34481471

Group type: EXPERIMENTAL
Intervention: Hindi version of the London Measure of Unplanned Pregnancy (LMUP)
Number of subjects: 4991
Study: 33866003

Group type: EXPERIMENTAL
Intervention: Intravaginal Motion‐Based Digital Health System (PDHS) for Pelvic Floor Muscle Training (PFMT)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Home Kegel exercise program (Control)
Number of subjects: 350
Study: 32538776

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus (2 strains, 5 x 10^9 cfu/capsule)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 35455507

Group type: EXPERIMENTAL
Intervention: Massage with oil (isio4 10 mL/kg/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No oil massage
Number of subjects: 36
Study: 32391156

Group type: COMPARATOR
Intervention: 23.4% NaCl
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 16.4% NaCl/Na-acetate
Number of subjects: 59
Study: 35758895

Group type: EXPERIMENTAL
Intervention: Adenosine A2A receptor antagonist
Number of subjects: 236

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study: 34937681

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 73
Study: 34606578

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (2 units, total volume of 550 mL)
Number of subjects: 2011

Group type: COMPARATOR
Intervention: No convalescent plasma
Number of subjects: 2011

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 2011
Study: 36224523

Group type: EXPERIMENTAL
Intervention: Body-focused social media posts
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control set of infant feeding tips
Number of subjects: 132
Study: 33609277

Group type: EXPERIMENTAL
Intervention: Sarcopenic resistance training (RT)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Non-sarcopenic resistance training (RT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Sarcopenic control
Number of subjects: 107

Group type: COMPARATOR
Intervention: Non-sarcopenic control
Number of subjects: 107
Study: 32442205

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 71
Study: 36422222

Group type: EXPERIMENTAL
Intervention: Individualized hemodynamic management based on continuously non‐invasively measured blood pressure, heart rate, cardiac output, systemic vascular resistance, and stroke volume variation.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional hemodynamic monitoring with intermittent non‐invasive blood pressure measurements.
Number of subjects: 50
Study: 34507573

Group type: EXPERIMENTAL
Intervention: Medical treatment (n=382)
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Surgical treatment (Roux-en-Y gastric bypass, n=388; sleeve gastrectomy, n=201)
Number of subjects: 971
Study: 35864562

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (traditional anesthesia)
Number of subjects: 100
Study: 33530156

Group type: EXPERIMENTAL
Intervention: Progressive neuromuscular stabilization exercise on unstable surface
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intensive progressive exercise on stable surface
Number of subjects: 46
Study: 32380460

Group type: EXPERIMENTAL
Intervention: Transdisciplinary intervention (2 visits with a geriatrician)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study: 35452273

Group type: EXPERIMENTAL
Intervention: Durvalumab plus oleclumab
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Durvalumab plus monalizumab
Number of subjects: 189

Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 189
Study: 33295083

Group type: EXPERIMENTAL
Intervention: Inhaled PDE4i CHF6001 (tanimilast)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 36447137

Group type: EXPERIMENTAL
Intervention: 20 ml of 0.375% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 30 ml of 0.375% ropivacaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 40 ml of 0.375% ropivacaine
Number of subjects: 30
Study: 34829373

Group type: EXPERIMENTAL
Intervention: Acoustic stimulation (group A)
Number of subjects: 210

Group type: COMPARATOR
Intervention: No stimulation (group B)
Number of subjects: 210
Study: 32092310

Group type: EXPERIMENTAL
Intervention: IW-3718 1500 mg
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: IW-3718 500 mg
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: IW-3718 1000 mg
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: IW-3718
Number of subjects: 280
Study: 36300974

Group type: EXPERIMENTAL
Intervention: DHA group (60 mg of DHA per kilogram of body weight per day)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 480
Study: 34954967

Group type: EXPERIMENTAL
Intervention: 0-14 day immunization schedule
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: 0-21 day immunization schedule
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: 0-28 day immunization schedule
Number of subjects: 405
Study: 35972259

Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed-loop (AHCL) system
Number of subjects: 41

Group type: COMPARATOR
Intervention: MDI+BGM
Number of subjects: 41
Study: 33346335

Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg/d)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Efavirenz-based therapy
Number of subjects: 28
Study: 34010611

Group type: EXPERIMENTAL
Intervention: Ultrasound renal denervation
Number of subjects: 989

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 989
Study: 35902939

Group type: EXPERIMENTAL
Intervention: Tiotropium via Respimat® with spacer (AeroChamber®)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Tiotropium via Respimat® without spacer
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Tiotropium via Respimat® with spacer
Number of subjects: 96
Study: 35077334

Group type: EXPERIMENTAL
Intervention: Stroop task (30 min)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control task (15 min)
Number of subjects: 36
Study: 35997319

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 15201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15201
Study: 32333636

Group type: EXPERIMENTAL
Intervention: Financial toxicity sources including travel to and from the hospital and reduced working hours during treatment
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Workplace flexibility
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Low socioeconomic areas
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Mothers on maternity leave during diagnosis
Number of subjects: 56
Study: 35936068

Group type: EXPERIMENTAL
Intervention: Ketamine (10 μg/kg/min)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg/h)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 90
Study: 32918779

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cox proportional hazard model and additive hazard model
Number of subjects: 0
Study: 32224318

Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 165

Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: NTCP model-based approach
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Model-based trial approach
Number of subjects: 165
Study: 34744066

Group type: EXPERIMENTAL
Intervention: WeChat-based individualized rehabilitation program (10 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Routine follow-up guidance
Number of subjects: 72
Study: 33333508

Group type: EXPERIMENTAL
Intervention: Routine physical therapy with VR and MI techniques, 60-min sessions, every alternate day for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine physical therapy, 40-min sessions, 20 min of walking and cycling, every alternate day for 12 weeks
Number of subjects: 34
Study: 32694748

Group type: EXPERIMENTAL
Intervention: Telehealth-based physical activity counseling intervention (adapted from the 16-session Diabetes Prevention Program)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Usual care (UC) control
Number of subjects: 15
Study: 33228625

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) package offered to half of the smokers interested in receiving it.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No nicotine patches offered to the other half of smokers.
Number of subjects: 0
Study: 35389359

Group type: EXPERIMENTAL
Intervention: Pharmacist-led web-based medication adherence tool with patient-centered communication
Number of subjects: 492

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 492
Study: 35222585

Group type: EXPERIMENTAL
Intervention: Life style intervention (group A, n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (group B, n=40)
Number of subjects: 80
Study: 35763327

Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) with insulin aspart or insulin lispro, N=112
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) for participants with baseline HbA1c ≥9.0% (N=34)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard Care (SC), N=53
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 165
Study: 34058560

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 104
Study: 32035035

Group type: EXPERIMENTAL
Intervention: Group Support Psychotherapy (GSP)
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Group HIV Education (GHE)
Number of subjects: 1140
Study: 35661358

Group type: EXPERIMENTAL
Intervention: 90% bovine-derived xenograft granules in a 10% porcine collagen matrix (Group A)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 80% microparticulate hydroxyapatite alloplast graft with 20% sugar cross-linked porcine type 1 collagen (Group B)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 54
Study: 35837133

Group type: EXPERIMENTAL
Intervention: Flexible bronchoscope
Number of subjects: 48

Group type: COMPARATOR
Intervention: Video laryngoscope
Number of subjects: 48
Study: 32037283

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 35857546

Group type: EXPERIMENTAL
Intervention: Women’s Help Desks (WHDs) in police stations, staffed by trained officers.
Number of subjects: 23400000

Group type: COMPARATOR
Intervention: Control group (police stations without WHDs)
Number of subjects: 23400000
Study: 34758970

Group type: EXPERIMENTAL
Intervention: Information intervention for group A (n=246) that explicitly discussed misinformation and provided scientifically correct information.
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Information intervention for group B (n=245) that only provided correct information without discussing misinformation.
Number of subjects: 736

Group type: COMPARATOR
Intervention: Control group (n=245) who received two episodes about breastfeeding.
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Both interventions (A and B).
Number of subjects: 736
Study: 35980872

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Stretching exercise
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 33516859

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied to the left M1.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Single-pulse transcranial magnetic stimulation (TMS) targeting the left primary motor cortex (M1).
Number of subjects: 18
Study: 35051142

Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) group
Number of subjects: 120
Study: 34488646

Group type: EXPERIMENTAL
Intervention: Propofol TCI with Narcotrend monitor during the day (Group ND)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol TCI with Narcotrend monitor during the night (Group NN)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol closed-loop TCI guided by BIS during the day (Group CLTD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol closed-loop TCI guided by BIS during the night (Group CLTN)
Number of subjects: 60
Study: 34362344

Group type: EXPERIMENTAL
Intervention: NACT + SBRT + durvalumab + oleclumab
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NACT + SBRT + durvalumab
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NACT + SBRT + oleclumab
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NACT + SBRT
Number of subjects: 136
Study: 32271710

Group type: EXPERIMENTAL
Intervention: Topical silicone-based scar cream containing selective synthetic recombinant human growth factors, hyaluronic acid, and vitamin C applied twice a day for 1 month.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Topical silicone-based scar cream (treated group)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Untreated SD (control group)
Number of subjects: 22
Study: 35468093

Group type: EXPERIMENTAL
Intervention: Personalized Nutrition (PN) advice via the eNutri web app
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control advice (population-based healthy eating guidelines)
Number of subjects: 210
Study: 33706428

Group type: EXPERIMENTAL
Intervention: Stepwise pain management (oral acetaminophen 10-15 mg/kg every 4-6 hours for moderate pain, morphine 0.1-0.2 mg/kg every 4 hours for severe pain)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Traditional pain management
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Stepwise pain management
Number of subjects: 196
Study: 36098301

Group type: EXPERIMENTAL
Intervention: Journeying through Dementia (JtD) intervention plus standard care
Number of subjects: 480

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Journeying through Dementia (JtD) intervention
Number of subjects: 480
Study: 34144603

Group type: EXPERIMENTAL
Intervention: MTX-PGs quartiles (specifically MTX-PGs 3-5)
Number of subjects: 2391

Group type: EXPERIMENTAL
Intervention: MTX-PGs levels >134 nmol/l
Number of subjects: 2391
Study: 32651163

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34556722

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen treatment (35% fraction of inspired oxygen)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Room air (21% fraction of inspired oxygen)
Number of subjects: 55
Study: 34667023

Group type: EXPERIMENTAL
Intervention: Epirubicin/cyclophosphamide followed by nivolumab, triptorelin, and exemestane
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 43
Study: 32539150

Group type: EXPERIMENTAL
Intervention: Individual telephone counseling
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Group telephone counseling
Number of subjects: 445

Group type: COMPARATOR
Intervention: Email education control
Number of subjects: 445
Study: 35115250

Group type: EXPERIMENTAL
Intervention: Diabetes health coaching intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study: 33103770

Group type: EXPERIMENTAL
Intervention: CCB + statin group
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: valsartan group
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: valsartan + statin group
Number of subjects: 189

Group type: COMPARATOR
Intervention: CCB group
Number of subjects: 189
Study: 34894205

Group type: EXPERIMENTAL
Intervention: Stereoscopic 3D view
Number of subjects: 66

Group type: COMPARATOR
Intervention: Monoscopic 3D view
Number of subjects: 66
Study: 34247727

Group type: EXPERIMENTAL
Intervention: Job applicants with 'foreign' names in high-skilled positions
Number of subjects: 6407

Group type: EXPERIMENTAL
Intervention: Job applicants with 'foreign' names in low-skilled positions
Number of subjects: 6407

Group type: EXPERIMENTAL
Intervention: Male job applicants with 'foreign' names
Number of subjects: 6407
Study: 32353623

Group type: EXPERIMENTAL
Intervention: Labral size in the upper decile of the cohort
Number of subjects: 571

Group type: COMPARATOR
Intervention: Labral width
Number of subjects: 571

Group type: COMPARATOR
Intervention: Labral size
Number of subjects: 571
Study: 35940872

Group type: EXPERIMENTAL
Intervention: Dextrose gel (40% dextrose)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 185
Study: 33642566

Group type: EXPERIMENTAL
Intervention: Intervention group (338 patients)
Number of subjects: 694

Group type: COMPARATOR
Intervention: Control group (356 patients)
Number of subjects: 694
Study: 32224029

Group type: EXPERIMENTAL
Intervention: Classical linear incision (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Modified Dandy incision (n=20)
Number of subjects: 40
Study: 35866509

Group type: EXPERIMENTAL
Intervention: Carotid-femoral pulse-wave velocity (cfPWV)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Brachial-femoral pulse-wave velocity (bfPWV)
Number of subjects: 18
Study: 34052785

Group type: EXPERIMENTAL
Intervention: mHealth technology-centered intervention using a Vaica electronic pill tray and blue-toothed UA-767Plus BT blood pressure device with a dedicated app for data relay.
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: mHealth technology-centered intervention
Number of subjects: 200
Study: 36478707

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil (2 μg) with 10 mg intrathecal bupivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (10 μg) with 10 mg intrathecal bupivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Intravenous cocktail of 1 g acetaminophen, 5 mg morphine, and 100 μg fentanyl with 10 mg intrathecal bupivacaine
Number of subjects: 105
Study: 33181549

Group type: EXPERIMENTAL
Intervention: Implantation of autologous adipose‐derived adult stem cells
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Decellularized donor corneal stroma laminas
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Implantation of recellularized donor laminas with adipose‐derived adult stem cells
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Allogenic SMILE implantation lenticule corneal inlays
Number of subjects: 14
Study: 34474038

Group type: EXPERIMENTAL
Intervention: PTG-100 (150, 300, or 900 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33177476

Group type: EXPERIMENTAL
Intervention: Low-dose methotrexate (LDMTX) 10 mg
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 33047449

Group type: EXPERIMENTAL
Intervention: Aerobic exercise associated with abdominal laser therapy (LLLT) for 50 minutes at 45%-55% of reserve heart rate
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Aerobic exercise only (without LLLT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo group (only LLLT without power)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Experimental groups (EG1 and EG2)
Number of subjects: 36
Study: 32395870

Group type: EXPERIMENTAL
Intervention: Matching-Adjusted Indirect Comparison (MAIC) using Method of Moments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Matching-Adjusted Indirect Comparison (MAIC) using Entropy Balancing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard MAIC (based on Method of Moments)
Number of subjects: 0
Study: 35668346

Group type: EXPERIMENTAL
Intervention: Delamanid alone
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Delamanid coadministered with Bedaquiline
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: DM-6705 metabolite
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Impact of plasma albumin concentrations
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Patients’ demographics (including HIV)
Number of subjects: 52
Study: 33526499

Group type: EXPERIMENTAL
Intervention: Link worker intervention over a 1-month period
Number of subjects: 600

Group type: COMPARATOR
Intervention: Wait list control receiving usual GP care
Number of subjects: 600
Study: 35332237

Group type: EXPERIMENTAL
Intervention: Head positioning intervention (supine position, head position changed every 2 hours to one of six randomized modes)
Number of subjects: 39
Study: 32139216

Group type: EXPERIMENTAL
Intervention: Direct TAVR without prior balloon valvuloplasty (n=97)
Number of subjects: 236

Group type: COMPARATOR
Intervention: TAVR with prior balloon valvuloplasty (BAV) (n=87)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Direct TAVR without prior BAV
Number of subjects: 236

Group type: COMPARATOR
Intervention: BAV group
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Direct implantation group
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 236
Study: 37434189

Group type: EXPERIMENTAL
Intervention: Chiropractic manipulation
Number of subjects: 199

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 199
Study: 33762197

Group type: EXPERIMENTAL
Intervention: USG transmuscular quadratus lumborum block (QLB)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Unilateral USG posterior transversus abdominis plane (TAP) block
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no blocks)
Number of subjects: 48